Crossmark

Lesion detection performance of an abbreviated gadoxetic acid–enhanced MRI protocol for colorectal liver metastasis surveillance

Crossref DOI link: https://doi.org/10.1007/s00330-019-06113-y

Published Online: 2019-03-19

Published Print: 2019-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Canellas, Rodrigo https://orcid.org/0000-0002-1984-8867
Patel, Midhir J.

Agarwal, Sheela

Sahani, Dushyant V.
Funding

Funding for this research was provided by:

Bayer Corporation
License Information

Text and Data Mining valid from 2019-03-19
More Information

Article History

Received: 30 October 2018

Revised: 7 February 2019

Accepted: 14 February 2019

First Online: 19 March 2019

Compliance with ethical standards

:

: The scientific guarantor of this publication is Dushyant V. Sahani.

: One of the authors of this manuscript declares relationships with the following companies: Bayer US. The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

: Some complex statistical methods were necessary for this paper.

: Written informed consent was waived by the Institutional Review Board.

: Institutional Review Board approval was obtained.

: • retrospective• experimental• performed at one institution